Is Phenobarbital an Effective Treatment for Alcohol Withdrawal Syndrome?

被引:0
|
作者
Long, Brit [1 ]
Keim, Samuel M. [2 ]
Gottlieb, Michael [3 ]
Rathlev, Niels [4 ]
机构
[1] Brooke Army Med Ctr, Dept Emergency Med, Ft Sam Houston, TX, Mexico
[2] Univ Arizona, Dept Emergency Med, Tucson, AZ 85724 USA
[3] Rush Univ, Dept Emergency Med, Med Ctr, Chicago, IL USA
[4] Univ Massachusetts, Dept Emergency Med, Chan Med Sch Baystate, Springfield, MA USA
来源
JOURNAL OF EMERGENCY MEDICINE | 2024年 / 67卷 / 05期
关键词
drawal syndrome; phenobarbital; benzodiazepines; GABA; admission. He denies recent trauma; chest pain; shortness; EMERGENCY-DEPARTMENT VISITS; MANAGEMENT;
D O I
10.1016/j.jemermed.2024.05.007
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Alcohol use disorder is associated with a variety of complications, including alcohol withdrawal syndrome (AWS), which may occur in those who decrease or stop alcohol consumption suddenly. AWS is associated with a range of signs and symptoms, which are most commonly treated with GABAergic medications. Clinical Question: Is phenobarbital an effective treatment for AWS? Evidence Review: Studies retrieved included two prospective, randomized, double-blind studies and three systematic reviews. These studies provided estimates of the effectiveness and safety of phenobarbital for treatment of AWS. Conclusions: Based on the available literature, phenobarbital is reasonable to consider for treatment of AWS. Clinicians must consider the individual patient, clinical situation, and comorbidities when selecting a medication for treatment of AWS. (c) 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:e494 / e503
页数:10
相关论文
共 50 条
  • [41] Phenobarbital for Severe Alcohol Withdrawal Syndrome: A Multicenter Retrospective Cohort Study
    Bosch, Nicholas A.
    Law, Anica C.
    Walkey, Allan J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (09) : 1171 - 1174
  • [42] Phenobarbital Versus Benzodiazepines in Alcohol Withdrawal Syndrome: A Meta-Analysis
    Sahu, A.
    Galwankar, S.
    Aggarwal, P.
    ANNALS OF EMERGENCY MEDICINE, 2023, 82 (04) : S19 - S19
  • [43] Evaluating the Use of Phenobarbital for the Management of Alcohol Withdrawal Syndrome in Psychiatric Inpatients
    Waldee, Erin
    Phan, Stephanie V.
    JOURNAL OF PHARMACY PRACTICE, 2020, 33 (04) : 477 - 480
  • [44] PHENOBARBITAL COMPARED TO BENZODIAZEPINES FOR ALCOHOL WITHDRAWAL SYNDROME IN THE INTENSIVE CARE UNIT
    Boyd, Carly
    Moon, Julie
    Sikand, Harminder
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 465 - 465
  • [45] PHENOBARBITAL VERSUS BENZODIAZEPINES FOR ALCOHOL WITHDRAWAL SYNDROME IN THE INTENSIVE CARE UNIT
    Butler, Katelyn
    Phillips, Hillary
    Price, Christine
    Davila, Lawrence
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [46] Phenobarbital vs Lorazepam for Alcohol Withdrawal Syndrome: A Retrospective Cohort Study
    Hawa, Fadi
    Gilbert, Linsey
    Gilbert, Benjamin
    Hereford, Vanessa
    Weiner, Mark
    Al Sous, Ola
    AMERICAN JOURNAL ON ADDICTIONS, 2020, 29 (03): : 216 - 216
  • [47] PHENOBARBITAL VERSUS DEXMEDETOMIDINE AS ADJUNCT THERAPY FOR REFRACTORY ALCOHOL WITHDRAWAL SYNDROME
    Soucek, Dana
    Gladden, Dustin
    DeHoff, Kaitlyn
    CRITICAL CARE MEDICINE, 2019, 47
  • [48] The Safety and Utility of Phenobarbital Use for the Treatment of Severe Alcohol Withdrawal Syndrome in the Medical Intensive Care Unit
    Oks, Margarita
    Cleven, Krystal L.
    Healy, Lauren
    Wei, Mabel
    Narasimhan, Mangala
    Mayo, Paul H.
    Kohn, Nina
    Koenig, Seth
    JOURNAL OF INTENSIVE CARE MEDICINE, 2020, 35 (09) : 844 - 850
  • [49] Establishing the safety of phenobarbital treatment of alcohol withdrawal syndrome on general medical wards: A retrospective cohort study
    Ronan, Matthew, V
    Ganatra, Rahul B.
    Saukkonen, Jussi
    ALCOHOL, 2024, 116 : 29 - 34
  • [50] Treatment of alcohol withdrawal syndrome with gabapentin
    Bonnet, U
    Banger, M
    Leweke, FM
    Maschke, M
    Kowalski, T
    Gastpar, M
    PHARMACOPSYCHIATRY, 1999, 32 (03) : 107 - 109